tradingkey.logo
tradingkey.logo
Search

Candel Therapeutics Inc

CADL
Add to Watchlist
11.550USD
+0.260+2.30%
Close 09-23 16:00(ET)
846.27MMarket Cap
LossP/E TTM
After-hours 16:26 (ET)11.390USD-0.170-1.47%
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.30%

5 Days

+4.81%

1 Month

-12.03%

6 Months

+131.46%

Year to Date

+104.42%

1 Year

+118.34%

Key Figures

11.220Open
12.006High
51.97KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
11.290Prev. Close
10.850Low
585.11KTurnover
LossP/E Static
6.72P/B
0.00%Div Yield TTM
-36.55%ROA
14.00052wk High
14.33Volume Ratio
-55.18MNet Profit
73.27MShares
-1.0092EPS TTM
-0.51Beta
-51.17%ROE
4.35052wk Low
10.24%Amplitude
100.00%Gross Margin
846.27MMarket Cap
5.39Reward/Risk
4.59%Risk Rate
More news coming soon, stay tuned...

Candel Therapeutics Inc's Score

-0.04vs previous score
Forecast8.22
Financial Health6.26
Technical5.05
Valuation Dimensions7.94
Institutional Confidence3.00
Risk Assessment5.06

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
21.750Target Price
+92.65%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy22222222
Buy66655555
Hold11111111
Sell00000000
Strong Sell00000000

Candel Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.52/-0.24
Revenue / Forecast
--/0.00

Candel Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolCADL
Number of employees38
CountryUnited States of America

Ownership

ShareholdersProportion
Fidelity Management & Research Company LLC11.24%
Manning (Paul B.)6.07%
BlackRock Institutional Trust Company, N.A.3.54%
Acorn Capital Advisors, LLC3.52%
Shareholder TypesProportion
Investment Advisor26.03%
Individual Investor14.01%
Investment Advisor/Hedge Fund6.53%
Corporation1.78%

FAQs

What is the current price of Candel Therapeutics Inc (CADL)?

The current price of Candel Therapeutics Inc (CADL) is 11.29.

What is the symbol of Candel Therapeutics Inc?

The ticker symbol of Candel Therapeutics Inc is CADL.

What is the 52-week high of Candel Therapeutics Inc?

The 52-week high of Candel Therapeutics Inc is 14.00.

What is the 52-week low of Candel Therapeutics Inc?

The 52-week low of Candel Therapeutics Inc is 4.35.

What is the market capitalization of Candel Therapeutics Inc?

The market capitalization of Candel Therapeutics Inc is 827.22M.

Is Candel Therapeutics Inc (CADL) currently rated as Buy, Hold, or Sell?

According to analysts, Candel Therapeutics Inc (CADL) has an overall rating of Buy, with a price target of 21.75.

What is the Earnings Per Share (EPS TTM) of Candel Therapeutics Inc (CADL)?

The Earnings Per Share (EPS TTM) of Candel Therapeutics Inc (CADL) is -1.01.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.